AdvaMedDx 2022 Priorities
AdvaMed and AdvaMedDx have prioritized supporting Medtech’s mobilization to the pandemic to protect patients and public health.
Diagnostics
Learn more about our Diagnostics work.
Canadian Hospital Specialties Limited Joins AdvaMed, the World’s Leading Medical Technology Trade Association
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association (AdvaMed), the world’s leading trade association representing more than 400…
Medtech Poised to Make Significant Contribution to White House Cancer Moonshot
Chairman and CEO of Edwards Lifesciences, Mike Mussallem joins AdvaMed’s Scott Whitaker to discuss the dedication of those in the industry and how policy reform can help speed up the…
AdvaMed Commends White House on Relaunch of Cancer Moonshot
In a letter to President Joe Biden today, AdvaMed President and CEO Scott Whitaker thanked the Administration for relaunching the Cancer Moonshot with an emphasis on cancer screening and advances…
AdvaMed Urges Administration to Prioritize Health Care Industry Amidst Semiconductor Shortage
Today, the Advanced Medical Technology Association (AdvaMed) responded to the Department of Commerce following the release of a report on a recent request for information on the semiconductor supply chain.…
Medtech POV Podcast with Scott Whitaker | Abbott’s Lisa Earnhardt Discusses How Technology and Innovation are Making it Easier and More Affordable to Manage Diabetes
Lisa Earnhardt, Executive Vice President, Medical Devices, at Abbott joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to discuss how innovation and technology are helping patients manage diabetes, allowing…
Medtech POV Podcast with Scott Whitaker | Edwards Lifesciences CEO Mike Mussallem Discusses Opportunities for Getting Life-Saving Technologies to Patients
Mike Mussallem, Chairman and CEO of Edwards Lifesciences, joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to talk about policy opportunities that could improve the process of getting life-saving medical technologies…
AdvaMed: Administration Plan to Purchase 500 Million Covid Tests an “Encouraging Next Step,” Says More Must Be Done
Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker regarding the White House’s newest measures to address the COVID-19 pandemic and rising…
AdvaMed Commends Administration Move to Increase Access to At-Home Covid Tests Through Private Insurance Coverage, Expansion of Testing Access in Vulnerable Communities
AdvaMed released the following statement from President and CEO Scott Whitaker on the Administration’s announcement today that, (1) beginning in January, private insurance plans will cover the cost of at-home…
AdvaMed Statement on HHS Reversal of LDT Rescission Notice
Today, the Advanced Medical Technology Association (AdvaMed) released the following statement from President and CEO Scott Whitaker following the Department of Health and Human Services’ announcement regarding new requirements for…